in silico prediction
of new drug efficacy

Novadiscovery builds knowledge-driven models applied to virtual patients
and runs in silico clinical trials to de-risk and optimize R&D.

We help biotech and pharma companies sort through target combinations
in drug discovery, optimize the design of future clinical trials (best regimen,
optimal responders…), and assist with the value demonstration efforts
in market access.

Who we are

Braintrust

Worldwide experts from academia and industry endorsing Novadiscovery’s approach.

What we do

Discovery collaborations

For streamlined target identification & secured proof of concept.

What we do

Clinical insights & strategy

A digital sandbox to optimize trial design and capture best responders.

How we do it

The WISE engine

To ensure full traceability from a simulation output back to each primary source and avoid the black box syndrome.

How we do it

The effect model

The result of decades of experience in clinical trials methodology, the Effect Model law has solved the main problem plaguing the development of in silico clinical trials: the paradigm of efficacy.

careers

Join Nova

We’re constantly on the hunt for the most talented individuals in our industry. If you have a knack for the development of mathematical and computational models of biological systems or if you are a genius developer with a keen interest in working on a state-of-the-art platform, fill the application form.

Les ateliers de Giens

Les ateliers de Giens

6ème journée de restitution Nationale des Ateliers de Giens
Le 20 mars 2019 de 9h30 – 16h30 – Amphithéâtre Duclaux – Institut Pasteur, Paris 15e

François-Henri Boissel, CEO de NOVADISCOVERY, interviendra dans le cadre de la table ronde sur l’Intelligence Artificielle.

BIO 2019

BIO 2019

The BIO International Convention (BIO) attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships.

BIO-Europe Spring

BIO-Europe Spring

This year’s event in Vienna will bring together the “who’s who” from the biotech, pharma and finance segments to allow delegates to meet more key decision makers in three days of partnering meetings than they could in a whole year.

ICSB 2018

ICSB 2018

Two posters presented by Novadiscovery’s team at ICSB 2018, October 28 – November 1, 2018.
#realICSB2018